Beryl Drugs Ltd

Thu 1/10/2026,16:1:0 | BSE : BERLDRG

₹25.970.32 (1.25%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 25.00

Previous Close

₹ 25.65

Volume

4027

Mkt Cap ( ₹ Cr)

₹ 13.17

High

₹ 26.90

Low

₹ 24.05

52 Week High

₹ 27.60

52 Week Low

₹ 15.92

Book Value Per Share

₹ 19.89

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Beryl Drugs Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Beryl Drugs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Beryl Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 7:30PM VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026

  • Beryl Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 7:30PM VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026

  • Beryl Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 7:30PM VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026

  • Beryl Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 7:30PM VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026

  • Beryl Drugs - PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026

    29 Sep 2026, 2:33PM PROCEEDINGS OF 33RD ANNUAL GENERAL MEETING

  • Beryl Drugs - Approval For Increase In The Limit Of Material Related Party Transactions With M/S. Aminova Infusions Pvt. Ltd.

    29 Sep 2026, 11:52AM considered and approved the increase in limit of material related party transactions with M/S. AMINOVA INFUSIONS PVT. LTD.

  • Beryl Drugs - Shareholder Meeting / Postal Ballot-Outcome of AGM

    29 Sep 2026, 11:35AM OUTCOME OF 33RD ANNUAL GENERAL MEETING

  • Beryl Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 7:30PM VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026

  • Beryl Drugs - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    30 Sep 2026, 7:30PM VOTING RESULTS OF 33RD ANNUAL GENERAL MEETING HELD ON 29TH SEPTEMBER, 2026

  • Beryl Drugs - Reg. 34 (1) Annual Report.

    3 Sep 2026, 6:37PM ANNUAL REPORT 2025-2026

  • Beryl Drugs - 33RD ANNUAL GENERAL MEETING NOTICE TO BE HELD ON 29TH SEPTEMBER, 2026 AT 11 A.M. AT KANCHAN PALACE COMMUNITY HA

    3 Sep 2026, 4:04PM 33RD ANNUAL GENERAL MEETING NOTICE

  • Beryl Drugs - EVOTING DATE FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING

    3 Sep 2026, 12:02AM EVOTING DATES FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING

  • Beryl Drugs - RECORD DATE FOR THE PURPOSE OF 33RD ANNUAL GENERAL MEETING

    3 Sep 2026, 12:00AM RECORD DATE

  • Beryl Drugs - ANNUAL BOOK CLOSURE

    2 Sep 2026, 11:58PM INTIMATION OF ANNUAL BOOK CLOSURE

  • Beryl Drugs - Board Meeting Outcome for OUTCOME OF BOARD MEETING

    2 Sep 2026, 5:11PM OUTCOME OF BOARD MEETING

  • Beryl Drugs - Board Meeting Intimation for Approve Board Report And Other Matters Related To 33Rd Annual General Meeting Of T

    27 Aug 2026, 9:46PM Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2026 ,inter alia, to consider and appr

  • Beryl Drugs Q1 net profit zooms 1000.00% at Rs 0.22 cr

    26 Aug 2026, 4:30PM The company reported standalone net profit of Rs 0.22 crore for the quarter ended June 30, 2026 as compared to Rs 0.02 crore in the same period last y

  • Beryl Drugs - UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2026

    11 Aug 2026, 5:16PM UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE, 2026

  • Beryl Drugs - Board Meeting Outcome for OUTCOME OF BOARD MEETING

    11 Aug 2026, 5:06PM OUTCOME OF BOARD MEETING

  • Beryl Drugs - Board Meeting Intimation for Consider And Approve The Unaudited Financial Results For The Quarter Ended 30Th Ju

    5 Aug 2026, 3:05PM Beryl Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and appr

  • Beryl Drugs - Intimation Regarding Temporary Unavailability Of The Company's Website Due To An Unexpected Technical Issue

    21 Jul 2026, 1:05PM TEMPORARY UNAVAILABILITY OF THE COMPANY'S WEBSITE \www.beryldrugs.com\ DUE TO AN UNEXPECTED TECHNICAL ISSUE.

  • Beryl Drugs - Intimation Regarding Temporary Unavailability Of The Company's Website Due To An Unexpected Technical Issue

    21 Jul 2026, 1:05PM TEMPORARY UNAVAILABILITY OF THE COMPANY'S WEBSITE \www.beryldrugs.com\ DUE TO AN UNEXPECTED TECHNICAL ISSUE.

  • Beryl Drugs - Intimation Regarding Temporary Unavailability Of The Company's Website Due To An Unexpected Technical Issue

    21 Jul 2026, 1:05PM TEMPORARY UNAVAILABILITY OF THE COMPANY'S WEBSITE \www.beryldrugs.com\ DUE TO AN UNEXPECTED TECHNICAL ISSUE.

  • Beryl Drugs - Intimation Regarding Temporary Unavailability Of The Company's Website Due To An Unexpected Technical Issue

    21 Jul 2026, 1:05PM TEMPORARY UNAVAILABILITY OF THE COMPANY'S WEBSITE \www.beryldrugs.com\ DUE TO AN UNEXPECTED TECHNICAL ISSUE.

  • Beryl Drugs - Intimation Regarding Temporary Unavailability Of The Company's Website Due To An Unexpected Technical Issue

    21 Jul 2026, 1:05PM TEMPORARY UNAVAILABILITY OF THE COMPANY'S WEBSITE \www.beryldrugs.com\ DUE TO AN UNEXPECTED TECHNICAL ISSUE.

  • Beryl Drugs - Intimation Regarding Temporary Unavailability Of The Company's Website Due To An Unexpected Technical Issue

    21 Jul 2026, 1:05PM TEMPORARY UNAVAILABILITY OF THE COMPANY'S WEBSITE \www.beryldrugs.com\ DUE TO AN UNEXPECTED TECHNICAL ISSUE.

  • Beryl Drugs has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    11 Jul 2026, 10:01PM As of June 2026, 27.82% is owned by Indian Promoters and 72.18% by Public. <p align=justify> Top four Promoters holding highest number of shares of Be

  • Beryl Drugs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    6 Jul 2026, 5:21PM CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS, 2018

  • Beryl Drugs - Compliance-57 (5) : intimation after the end of quarter

    6 Jul 2026, 5:19PM NON-APPLOCABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30TH JUNE, 2026
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Beryl Drugs Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 12.2788 13.5773 14.0172 12.6085 12.5872
Liabilities 12.2788 13.5773 14.0172 12.6085 12.5872
Equity 5.0937 5.0937 5.0937 5.0937 5.0937
Gross Profit 1.9355 1.2324 2.2788 1.9451 0.408
Net Profit 0.4248 0.5788 0.7686 0.766 -0.659
Cash From Operating Activities 3.6494 2.6366 0.8203 2.4804 -0.2867
NPM(%) 2.25 2.73 2.87 2.84 -4.51
Revenue 18.8202 21.1462 26.7296 26.8878 14.6037
Expenses 16.8847 19.9138 24.4508 24.9427 14.1957
ROE(%) 4.21 5.73 7.62 7.59 -6.53

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Beryl Drugs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 851.10 -2.37 21.67 14.43 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 116.45 0.39 1652.57 52.59 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 8.18 -9.71 0.00 109.20 -39.50 0.00
Astec Lifesciences Ltd 706.70 -2.03 0.00 56.35 -363.14 0.00

Company Info

1994 -The company was incorporated as a medicine pharmaceutical manufacturer. 2007 -The board of directors of the company at its meeting held on Nov.16, 2007 decided to issue 1.50 million equity shares and 2 million warrants to promoters and other strategic investors on preferential basis. -Board of the company had increased the authorized share capital of the company from Rs 5.50 crores to Rs 10.00 crores. 2008 -Board of directors of the company had approved to issue 35 lacs warrants to promoters and other strategic investors on preferential basis. 2015 -Beryl Drugs, MPPHSCL sign deal worth Rs 11.8 crores.

1994 -The company was incorporated as a medicine pharmaceutical manufacturer. 2007 -The board of directors of the company at its meeting held on Nov.16, 2007 decided to issue 1.50 million equity shares and 2 million warrants to promoters and other strategic investors on preferential basis. -Board of the company had increased the authorized share capital of the company from Rs 5.50 crores to Rs 10.00 crores. 2008 -Board of directors of the company had approved to issue 35 lacs warrants to promoters and other strategic investors on preferential basis. 2015 -Beryl Drugs, MPPHSCL sign deal worth Rs 11.8 crores.

Parent Organisation

Beryl Drugs Ltd.

Founded

24/08/1993

Managing Director

Mr.Sanjay Sethi

NSE Symbol

FAQ